Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA

This article was originally published in The Tan Sheet

Executive Summary

A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge

You may also be interested in...

FDA’s Plan B Approval Illegal, Unconstitutional, Federal Suit Says

FDA's approval for OTC distribution of Plan B emergency contraceptive violated the Food, Drug, and Cosmetic and Administrative Procedure acts, as well as the due process clause of the Constitution, according to an April 12 lawsuit seeking to overturn the approval

Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing

FDA's decision to approve emergency contraceptive Plan B for over-the-counter sale to women age 18 and older cracks open the door on a pharmacy-only, behind-the-counter model for nonprescription drug sales

FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns

The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts